-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fenfluramine Hydrochloride in Tonic-Clonic (Grand Mal) Seizure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fenfluramine Hydrochloride in Tonic-Clonic (Grand Mal) Seizure report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fenfluramine Hydrochloride in Tonic-Clonic (Grand Mal) Seizure Drug...
-
Product Insights
Dialogo Engenharia – Moema Mona The Grand Lodge – Sao Paulo
The Dialogo Engenharia – Moema Mona The Grand Lodge – Sao Paulo involves the construction of a residential complex in Moema, São Paulo, Brazil. Equip yourself with the essential tools needed to make informed and profitable decisions with our Dialogo Engenharia – Moema Mona The Grand Lodge – Sao Paulo report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and...
-
Innovation Ranking
Innovation Ranking – China Grand Pharmaceutical and Healthcare Holdings Ltd
Grand Pharmaceutical Group Ltd (Grand Pharmaceutical) is a manufacturer of medical devices. The company develops, manufactures, and distributes pharmaceutical preparations, medical devices pharmaceutical intermediates, specialized raw materials, and healthcare products. It also provides product categories such as preparations, APIs, steroid hormones APIs, healthcare products and agricultural, fine chemicals, and others. China Grand offers preparation products such as cardiovascular tablets, ophthalmic gel, eye drops, antibacterial, antibiotics, antipyretics and analgesic tablets, capsules, and injections. China Grand provides raw materials such as Chloramphenicol,...
-
Product Insights
Neoma BS – Neoma New Campus Reims – Grand-Est
The Neoma BS – Neoma New Campus Reims – Grand-Est involves the construction of a new school campus on a 1.8ha land area in Reims City, Grand Est Region, France. Equip yourself with the essential tools needed to make informed and profitable decisions with our Neoma BS – Neoma New Campus Reims – Grand-Est report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the...
-
Product Insights
EB Capital/ Sebigas Cotica – Triunfo Waste Treatment Plant – Rio Grande do Sul
The EB Capital/ Sebigas Cotica – Triunfo Waste Treatment Plant – Rio Grande do Sul involves the construction of a waste treatment plant in Triunfo, Rio Grande do Sul, Brazil. Equip yourself with the essential tools needed to make informed and profitable decisions with our EB Capital/ Sebigas Cotica – Triunfo Waste Treatment Plant – Rio Grande do Sul report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XEN-1101 in Tonic-Clonic (Grand Mal) Seizure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XEN-1101 in Tonic-Clonic (Grand Mal) Seizure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XEN-1101 in Tonic-Clonic (Grand Mal) Seizure Drug Details: XEN-1101 (1OP-2198)...
-
Sector Analysis
Business of the Tennis Grand Slams 2024 – Property Profile, Sponsorship and Media Landscape
Reasons to buy the ‘Business of the Tennis Grand Slams’ report: Analyze the four major tennis grand slams with a clear breakdown of the commercial revenue generated. Assess the main sponsorship rights at the slams and get a clear breakdown of the brands involved in the sport. Examine the biggest deals of each grand slam and insightful ideal analysis in terms of industry and brand location. Assess the main kit suppliers in the Tennis Grand Slams, covering the top 32...
-
Product Insights
Grand Prairie Wind Energy Park, US
Empower your strategies with our Grand Prairie Wind Energy Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a thorough understanding of the project’s core details and stages of development.. Monitor...
-
Product Insights
Tonic-Clonic (Grand Mal) Seizure – Drugs In Development, 2023
Global Markets Direct’s, ‘Tonic-Clonic (Grand Mal) Seizure - Drugs In Development, 2023’, provides an overview of the Tonic-Clonic (Grand Mal) Seizure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Tonic-Clonic (Grand Mal) Seizure, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Azetukalner in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Azetukalner in Major Depressive Disorder report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Azetukalner in Major Depressive Disorder Drug Details: Azetukalner (XEN-1101, 1OP-2198)...